WallStSmart
ALLO

Allogene Therapeutics Inc

NASDAQ: ALLO · HEALTHCARE · BIOTECHNOLOGY

$2.13
+0.95% today

Updated 2026-04-30

Market cap
$725.79M
P/E ratio
P/S ratio
7,784.36x
EPS (TTM)
$-0.87
Dividend yield
52W range
$1 – $4
Volume
10.3M

Allogene Therapeutics Inc (ALLO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+21.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+39.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.7%
2026-03-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$-0.17+24.6%$2.53$2.31-8.7%
2025-11-06$-0.19+13.6%$1.11$1.18+6.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.23$-0.17+24.6%
2025-09-30$-0.22$-0.19+13.6%
2025-06-30$-0.27$-0.23+14.8%
2025-03-31$-0.41$-0.28+31.7%
2024-12-31$-0.32$-0.28+13.4%$-22000.00-50.0%
2024-09-30$-0.33$-0.32+3.0%
2024-06-30$-0.35$-0.35+0.0%
2024-03-31$-0.41$-0.38+7.3%$22000.00-26.7%
2023-12-31$-0.45$-0.43+4.4%$-44000.00
2023-09-30$-0.52$-0.37+28.8%$22000.00
2023-06-30$-0.59$-0.53+10.2%$22000.00
2023-03-31$-0.62$-0.68-9.7%$30000.00

Frequently asked questions

Has Allogene Therapeutics Inc beaten earnings estimates?
Allogene Therapeutics Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +21.2% over the last 4 quarters.
How does ALLO stock react to earnings?
ALLO stock has moved an average of -1.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.